Induction of Apoptosis by L-carnitine Through Regulation of Two Main Pathways in Hepa1c1c 7 Cells
Overview
Authors
Affiliations
This study shows the effects of L-carnitine treatment on cell proliferation with hepa1c1c7 mouse cancer cells and NCTC 1469 normal cells. In an MTT assay, L-carnitine increased the number of dead hepa1c1c7 cells, while there was no difference in the number of NCTC 1469 cells. mRNA and protein levels of TNF-alpha, Fas, and caspase-8, which are closely related to cell apoptosis by a death ligand/receptor-dependent apoptosis pathway, were increased by L-carnitine treatment. In addition, L-carnitine treatment regulated mitochondria-dependent apoptosis pathways by inducing the up-regulation of caspase-9 and caspase-3 and the down-regulation of Bcl-2 in hepa1c1c 7 cells. Taken together, the findings of this study have demonstrated that L-carnitine could induce apoptosis in hepa1c1c7 cells by regulating Fas ligands and inhibiting the expression of Bcl-2. These results suggest that L: -carnitine treatment could be related to both a mitochondrion-dependent and a death ligand/receptor-dependent apoptosis pathway in hepa1c1c7 cells. Our results could give information for understanding the L-carnitine-induced apoptosis mechanism in some cancer cells.
Farahzadi R, Sanaat Z, Movassaghpour-Akbari A, Fathi E, Montazersaheb S Regen Ther. 2023; 24:219-226.
PMID: 37519907 PMC: 10384609. DOI: 10.1016/j.reth.2023.06.014.
Fathi E, Kholosi Pashutan M, Farahzadi R, Nozad Charoudeh H Iran J Vet Res. 2022; 22(4):264-271.
PMID: 35126533 PMC: 8806168. DOI: 10.22099/ijvr.2021.39045.5677.
Jeong H, Lee S, Kim S, Kim D, Han G Food Sci Biotechnol. 2018; 25(6):1727-1735.
PMID: 30263468 PMC: 6049242. DOI: 10.1007/s10068-016-0264-7.
Novel ethanocycloheptono [3,4,5-kl]benzo[a]xanthene induces apoptosis in BEL-7402 cells.
Jia Z, Yang H, Liu Y, Wang X Mol Cell Biochem. 2018; 445(1-2):145-156.
PMID: 29380241 DOI: 10.1007/s11010-017-3260-1.
Bioavailability of nanoemulsified conjugated linoleic acid for an antiobesity effect.
Kim D, Park J, Kweon D, Han G Int J Nanomedicine. 2013; 8:451-9.
PMID: 23429301 PMC: 3575163. DOI: 10.2147/IJN.S38430.